CASI PHARMACEUTICALS INC - COM (CASI)

CUSIP: 14757U109

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / COM
Total 13F shares
9,816,931
Share change
+4,846,975
Total reported value
$80,787,402
Price per share
$8.23
Number of holders
52
Value change
+$41,718,111
Number of buys
42
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 14757U109?
CUSIP 14757U109 identifies CASI - CASI PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CASI PHARMACEUTICALS INC - COM (CASI) as of Q2 2018

As of 30 Jun 2018, CASI PHARMACEUTICALS INC - COM (CASI) was held by 52 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,816,931 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Wellington Shields & Co., LLC, Wellington Shields Capital Management, LLC, STATE STREET CORP, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, and Bank of New York Mellon Corp. This page lists 52 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.